Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: A prospective randomised study

British Journal of Cancer

Volumn 50, Issue 6, 1984, Pages 753-756

  Hows, J M ^a   Mehta, A ^a   Ward, L ^a   Woods, K ^a   Perez, R ^a   Gordon, M Y ^a   Gordon Smith, E C ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BICARBONATE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FUROSEMIDE; GLUCOSE; MESNA; POTASSIUM CHLORIDE;

ADVERSE DRUG REACTION; APLASTIC ANEMIA; BLADDER; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW APLASIA; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DRUG THERAPY; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LYMPHATIC SYSTEM; LYMPHOCYTOPENIA; PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY; URINARY TRACT;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COLONY-FORMING UNITS ASSAY; CYCLOPHOSPHAMIDE; CYSTITIS; DIURESIS; GRAFT REJECTION; HEMATURIA; HEMORRHAGE; HUMANS; LEUKOCYTE COUNT; MERCAPTOETHANOL; MESNA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 0021686956     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1984.252     Document Type: Article

References (13)

1. BROCK, N., POHL, J. & STEKAR, J. (1981) Detoxification of urotoxic oxazaphosphorines by sulphydryl compounds. J. Cancer Res. Clin. Oncol., 100, 311.
2. BROCK, N., STEKAR, J., POHL, J., NIEMEYER, U. & SCHEFFLER, G. (1979). Acrolein The causative factor of urotoxic side effects of cyclophosphamide. Drug Res., 29, 659.
3. BRYANT, B.M., JARMAN, M., FORD, H.T. & SMITH, I.E. (1980). Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma. Lancet, ii, 657.
4. CAMITTA, B.M., THOMAS, E.D., NATHAN, D.G., SANTOS, G., GORDON-SMITH, E.C., GALE, R.P., RAPPEPORT, J.M. & STORB, R. (1976). Severe aplastic anaemia: a prospective study of the effect of early marrow transplantation on mortality. Blood, 48, 63.
5. COX, P.J. (1978). Cyclophosphamide cystitis - identification of acrolein as the causative agent. Biochem. Pharmacol. 28, 2045.
6. GEORGE, P. (1963). Haemorrhagic cystitis and cyclophosphamide. Lancet, ii, 942.
7. GLUCKSBERG, H., STORB, R., FEFER, A. & 5 others. (1974). Clinical manifestations of graft versus host disease in human recipients of marrow from HLA matched sibling donors. Transplantation, 18, 295.
8. GORDON-SMITH, E.C., HOWS, J., WOODS, K. & WARD, L. (1982). Mesna and fasle positive results in ward testing for urinary ketones. Lancet, 1, 503.
9. HOWS, J.M., CHIPPING, P.M., FAIRHEAD, S., BAUGHAN, A. & GORDON-SMITH, E.C. (1983a). Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A. Br. J. Haematol., 54, 69.
10. HOWS, J., MEHTA, A. & GORDON-SMITH, E.C. (1983b). Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data). Cancer Treat. Rev., 10 (Suppl.A) 53.
11. HOWS, J., PALMER, S. & GORDON-SMITH, E.C. (1982). Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anaemia. Transplantation, 33, 382.
12. LINK, H., NEEF, V., NIETHAMMER, D. & WILMS, K. (1981). Prophylaxis of haemorrhagic cystitis due to cyclophosphamide conditioning for bone marrow transplantation. Blut., 43, 329.
13. STORB, R., THOMAS, E.D., WEIDEN, P.L. & 10 others. (1976). Aplastic anemia treated by allogeneic bone marrow transplantation. A report on 49 new cases from Seattle. Blood, 48, 817.